Sigachi Industries FY25 revenue surges 25%, EBITDA 46%
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Annual EBITDA margin expands by 170 basis points
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
The 33% year-over-year revenue growth and a remarkable 45% surge in gross profit reflect our strong market presence and efficient execution across therapeutic segments
Shivani Satish Wagh takes on the role of Joint Managing Director
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Both organisations enter into a long- term collaboration to expand patient access in India
Investment is additive to KKR’s existing health care growth strategy
Subscribe To Our Newsletter & Stay Updated